Liuh-Yow Chen

Liuh-Yow Chen

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2012 in Nature
Verified
Journal Article
Closed access
PDF file
LCLiuh-Yow Chen
Liuh-Yow Chen
SRSophie Redon
Sophie Redon
JLJoachim Lingner
Joachim Lingner

16 November 2018 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
LKLi Teng Khoo
Li Teng Khoo
LCLiuh-Yow Chen
Liuh-Yow Chen

6 November 2017 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
YCYi-An Chen
Yi-An Chen
YSYi-Ling Shen
Yi-Ling Shen
HHHsuan-Yu Hsia
Hsuan-Yu Hsia
YTYee-Peng Tiang
Yee-Peng Tiang
TSTzu-Ling Sung
Tzu-Ling Sung
LCLiuh-Yow Chen
Liuh-Yow Chen
Extrachromosomal telomere repeat (ECTR) DNA is unique to cancer cells that maintain telomeres through the alternative lengthening of telomeres (ALT) pathway, but the role of ECTRs in ALT development remains elusive. We found that induction of ECTRs in normal human fibroblasts activated the cGAS-STING-TBK1-IRF3 signaling axis to trigger IFNβ production and a type I interferon response, resulting in cell-proliferation defects. In contrast, ALT cancer cells are commonly defective in sensing cytosolic DNA. We found that STING expression was inhibited in ALT cancer cell lines and transformed ALT cells. Notably, the ALT suppressors histone H3.3 and the ATRX–Daxx histone chaperone complex were also required to activate the DNA-sensing pathway. Collectively, our data suggest that the loss of the cGAS-STING pathway may be required to evade ECTR-induced anti-proliferation effects and permit ALT development, and this requirement may be exploited for treatments specific to cancers utilizing the ALT pathway.

1 February 2011 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
OLOk-Hee Lee
Ok-Hee Lee
HKHyeung Kim
Hyeung Kim
QHQuanyuan He
Quanyuan He
HBHwa Jin Baek
Hwa Jin Baek
DYDong Yang
Dong Yang
ZSZhou Songyang
Zhou Songyang
Detection of low-affinity or transient interactions can be a bottleneck in our understanding of signaling networks. To address this problem, we developed an arrayed screening strategy based on protein complementation to systematically investigate protein-protein interactions in live human cells, and performed a large-scale screen for regulators of telomeres. Maintenance of vertebrate telomeres requires the concerted action of members of the Telomere Interactome, built upon the six core telomeric proteins TRF1, TRF2, RAP1, TIN2, TPP1, and POT1. Of the ∼12,000 human proteins examined, we identified over 300 proteins that associated with the six core telomeric proteins. The majority of the identified proteins have not been previously linked to telomere biology, including regulators of post-translational modifications such as protein kinases and ubiquitin E3 ligases. Results from this study shed light on the molecular niche that is fundamental to telomere regulation in humans, and provide a valuable tool to investigate signaling pathways in mammalian cells.

15 March 2009 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
HKHyeung Kim
Hyeung Kim
OLOk-Hee Lee
Ok-Hee Lee
HXHuawei Xin
Huawei Xin
LCLiuh-Yow Chen
Liuh-Yow Chen
JQJun Qin
Jun Qin
ZSZhou Songyang
Zhou Songyang
TRF2 is a member of the telosome/shelterin complex, which helps maintain telomere integrity. Using an oriented peptide library based on a previously identified TRF2-interaction region to define a consensus sequence for binding, new proteins have been identified as TRF2 interactors and implicated in telomeric functions. This suggests that TRF2 acts as a hub for recruiting different proteins to the telomere via a distinct linear sequence. In mammalian cells, the telomeric repeat binding factor (TRF) homology (TRFH) domain–containing telomeric proteins TRF1 and TRF2 associate with a collection of molecules necessary for telomere maintenance and cell-cycle progression. However, the specificity and the mechanisms by which TRF2 communicates with different signaling pathways remain largely unknown. Using oriented peptide libraries, we demonstrate that the TRFH domain of human TRF2 recognizes [Y/F]XL peptides with the consensus motif YYHKYRLSPL. Disrupting the interactions between the TRF2 TRFH domain and its targets resulted in telomeric DNA-damage responses. Furthermore, our genome-wide target analysis revealed phosphatase nuclear targeting subunit (PNUTS) and microcephalin 1 (MCPH1) as previously unreported telomere-associated proteins that directly interact with TRF2 via the [Y/F]XL motif. PNUTS and MCPH1 can regulate telomere length and the telomeric DNA-damage response, respectively. Our findings indicate that an array of TRF2 molecules functions as a protein hub and regulates telomeres by recruiting different signaling molecules via a linear sequence code.

1 October 2013 in Genes & Development
Verified
Journal Article
Open access
PDF file
LCLiuh-Yow Chen
Liuh-Yow Chen
JMJana Majerská
Jana Majerská
JLJoachim Lingner
Joachim Lingner
Mutations in CTC1 lead to the telomere syndromes Coats Plus and dyskeratosis congenita (DC), but the molecular mechanisms involved remain unknown. CTC1 forms with STN1 and TEN1 a trimeric complex termed CST, which binds ssDNA, promotes telomere DNA synthesis, and inhibits telomerase-mediated telomere elongation. Here we identify CTC1 disease mutations that disrupt CST complex formation, the physical interaction with DNA polymerase α-primase (polα-primase), telomeric ssDNA binding in vitro, accumulation in the nucleus, and/or telomere association in vivo. While having diverse molecular defects, CTC1 mutations commonly lead to the accumulation of internal single-stranded gaps of telomeric DNA, suggesting telomere DNA replication defects as a primary cause of the disease. Strikingly, mutations in CTC1 may also unleash telomerase repression and telomere length control. Hence, the telomere defect initiated by CTC1 mutations is distinct from the telomerase insufficiencies seen in classical forms of telomere syndromes, which cause short telomeres due to reduced maintenance of distal telomeric ends by telomerase. Our analysis provides molecular evidence that CST collaborates with DNA polα-primase to promote faithful telomere DNA replication.